FDA Approved: PIASKY — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved PIASKY (crovalimab) from Genentech via an original BLA, marking its first regulatory approval as a new monoclonal antibody C5 complement inhibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• PIASKY (crovalimab)

Snippet

ORIG AP for PIASKY (CROVALIMAB)